Skip to main content
logo
Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.40
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
7.50
+0.10 (1.30%)
After-hours: Apr 2, 2026, 4:51 PM EDT

Kezar Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5546496894,8229,407
Market Cap Growth
28.24%-6.15%-92.88%-85.71%-48.74%288.71%
Enterprise Value
-15-25.82-70.51503.774,5649,211
Last Close Price
7.406.296.7294.70704.001672.00
PE Ratio
--0.82-0.58-6.75-69.50-160.77
PS Ratio
---98.46--
PB Ratio
0.770.660.423.6717.8747.78
P/TBV Ratio
0.770.660.423.6617.5744.81
P/FCF Ratio
--0.89-0.66-8.26-79.80-220.02
P/OCF Ratio
--0.89-0.66-8.44-81.94-221.66
EV/Sales Ratio
---71.97--
EV/EBITDA Ratio
-0.440.79-4.56-65.07-173.31
EV/EBIT Ratio
-0.440.78-4.52-64.14-168.52
EV/FCF Ratio
-0.500.95-6.04-75.53-215.45
Debt / Equity Ratio
-00.110.080.070.07
Debt / EBITDA Ratio
-0.04-0.04-0.18-0.17-0.30-0.26
Debt / FCF Ratio
-0.04-0.04-0.22-0.23-0.35-0.33
Net Debt / Equity Ratio
-0.99-0.99-0.99-0.97-0.95-0.99
Net Debt / EBITDA Ratio
1.201.201.301.653.643.66
Net Debt / FCF Ratio
1.341.341.562.194.224.55
Asset Turnover
-000.0300
Quick Ratio
10.9310.936.5111.3525.1525.37
Current Ratio
11.5211.526.7611.6625.9825.77
Return on Equity (ROE)
-60.12%-59.93%-55.00%-44.54%-29.24%-32.34%
Return on Assets (ROA)
-53.41%-53.41%-49.52%-42.79%-27.50%-29.56%
Return on Invested Capital (ROIC)
-8616.18%-8616.18%-3029.25%-1130.86%-830.36%-1273.95%
Return on Capital Employed (ROCE)
-60.80%-60.80%-55.27%-45.29%-28.56%-30.78%
Earnings Yield
-102.72%-121.78%-170.98%-14.83%-1.44%-0.62%
FCF Yield
-94.93%-112.42%-151.26%-12.11%-1.25%-0.45%
Buyback Yield / Dilution
-0.36%-0.37%-0.48%-7.70%-27.69%-19.90%
Total Shareholder Return
-0.36%-0.37%-0.48%-7.70%-27.69%-19.90%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q